2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced inflammatory activation is mediated by intracellular free calcium in microglial cells

Toxicology

Volumn 308, Issue , 2013, Pages 158-167

  Xu, Guangfei ^a,b   Li, Yuanye ^a   Yoshimoto, Katsuhiko ^b   Chen, Gang ^a   Wan, Chunhua ^a   Iwata, Takeo ^b   Mizusawa, Noriko ^b   Duan, Zhiqing ^a   Liu, Jiao ^a   Jiang, Junkang ^a  

^a NANTONG UNIVERSITY   (China)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

2,3,7,8 Tetrachlorodibenzo p dioxin (TCDD); Calcium; Inflammation; Microglia; Nuclear factor kappa B (NF B); Tumor necrosis factor alpha (TNF )

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; CALCIUM; CYCLOOXYGENASE 2; CYTOSOLIC PHOSPHOLIPASE A2; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; NIFEDIPINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CELL CULTURE; CELL LINE; CELL NUCLEUS; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOSOL; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; CALCIUM; INFLAMMATION; INTRACELLULAR FLUID; MICROGLIA; RATS; RATS, SPRAGUE-DAWLEY; TETRACHLORODIBENZODIOXIN;

EID: 84877349038     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2013.04.002     Document Type: Article

References (54)

1. Alsharif N.Z., Hassoun E., Bagchi M., Lawson T., Stohs S.J. The effects of anti-TNF-alpha antibody and dexamethasone on TCDD-induced oxidative stress in mice. Pharmacology 1994, 48:127-136.
2. Baeuerle P.A., Baltimore D. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 1988, 242:540-546.
3. Bales K.R., Du Y., Holtzman D., Cordell B., Paul S.M. Neuroinflammation and Alzheimer's disease: critical roles for cytokine/Abeta-induced glial activation, NF-kappaB, and apolipoprotein E. Neurobiol. Aging 2000, 21:427-432.
4. Block M.L., Zecca L., Hong J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 2007, 8:57-69.
5. Camacho I.A., Singh N., Hegde V.L., Nagarkatti M., Nagarkatti P.S. Treatment of mice with 2,3,7,8-tetrachlorodibenzo-p-dioxin leads to aryl hydrocarbon receptor-dependent nuclear translocation of NF-kappaB and expression of Fas ligand in thymic stromal cells and consequent apoptosis in T cells. J. Immunol. 2005, 175:90-103.
6. Charles G.D., Shiverick K.T. 2,3,7,8-Tetrachlorodibenzo-p-dioxin increases mRNA levels for interleukin-1beta, urokinase plasminogen activator, and tumor necrosis factor-alpha in human uterine endometrial adenocarcinoma RL95-2 cells. Biochem. Biophys. Res. Commun. 1997, 238:338-342.
7. Cheepsunthorn P., Radov L., Menzies S., Reid J., Connor J.R. Characterization of a novel brain-derived microglial cell line isolated from neonatal rat brain. Glia 2001, 35:53-62.
8. Cheng X., Kao H.Y. Microarray analysis revealing common and distinct functions of promyelocytic leukemia protein (PML) and tumor necrosis factor (TNF alpha) signaling in endothelial cells. BMC Genomics 2012, 13:453.
9. Cheon H., Woo Y.S., Lee J.Y., Kim H.S., Kim H.J., Cho S., Won N.H., Sohn J. Signaling pathway for 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced TNF-alpha production in differentiated THP-1 human macrophages. Exp. Mol. Med. 2007, 39:524-534.
10. Cui Z., Wang P., Sun L., Liu H., Yang J., Li X., Kang L., Huang Y., Shen A., Cheng C. Lipopolysaccharide-evoked HSPA12B expression by activation of MAPK cascade in microglial cells of the spinal cord. J. Neurol. Sci. 2010, 294:29-37.
11. Dong B., Matsumura F. Roles of cytosolic phospholipase A2 and Src kinase in the early action of 2,3,7,8-tetrachlorodibenzo-p-dioxin through a nongenomic pathway in MCF10A cells. Mol. Pharmacol. 2008, 74:255-263.
12. Dong B., Nishimura N., Vogel C.F., Tohyama C., Matsumura F. TCDD-induced cyclooxygenase-2 expression is mediated by the nongenomic pathway in mouse MMDD1 macula densa cells and kidneys. Biochem. Pharmacol. 2010, 79:487-497.
13. Farber K., Kettenmann H. Functional role of calcium signals for microglial function. Glia 2006, 54:656-665.
14. Ghosh S., Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002, 109(Suppl.):S81-S96.
15. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 1985, 260:3440-3450.
16. Hanneman W.H., Legare M.E., Barhoumi R., Burghardt R.C., Safe S., Tiffany-Castiglioni E. Stimulation of calcium uptake in cultured rat hippocampal neurons by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology 1996, 112:19-28.
17. Hayden M.S., Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004, 18:2195-2224.
18. He X., Shu J., Xu L., Lu C., Lu A. Inhibitory effect of Astragalus polysaccharides on lipopolysaccharide-induced TNF-α and IL-1beta production in THP-1 cells. Molecules 2012, 17:3155-3164.
19. Iannaccone S., Cerami C., Alessio M., Garibotto V., Panzacchi A., Olivieri S., Gelsomino G., Moresco R.M., Perani D. In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease. Parkinsonism Relat. Disord. 2012, 19:47-52.
20. Jackson-Bernitsas D.G., Ichikawa H., Takada Y., Myers J.N., Lin X.L., Darnay B.G., Chaturvedi M.M., Aggarwal B.B. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma. Oncogene 2007, 26:1385-1397.
21. Karras J.G., Morris D.L., Matulka R.A., Kramer C.M., Holsapple M.P. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) elevates basal B-cell intracellular calcium concentration and suppresses surface Ig- but not CD40-induced antibody secretion. Toxicol. Appl. Pharmacol. 1996, 137:275-284.
22. Kerkvliet N.I. TCDD: an environmental immunotoxicant reveals a novel pathway of immunoregulation - a 30-year odyssey. Toxicol. Pathol. 2012, 40:138-142.
23. Kerkvliet N.I., Baecher-Steppan L., Shepherd D.M., Oughton J.A., Vorderstrasse B.A., DeKrey G.K. Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Immunol. 1996, 157:2310-2319.
24. Kobayashi S., Okamoto H., Iwamoto T., Toyama Y., Tomatsu T., Yamanaka H., Momohara S. A role for the aryl hydrocarbon receptor and the dioxin TCDD in rheumatoid arthritis. Rheumatology (Oxford) 2008, 47:1317-1322.
25. Lappas M., Permezel M., Georgiou H.M., Rice G.E. Nuclear factor kappa B regulation of proinflammatory cytokines in human gestational tissues in vitro. Biol. Reprod. 2002, 67:668-673.
26. Lecureur V., Ferrec E.L., N'Diaye M., Vee M.L., Gardyn C., Gilot D., Fardel O. ERK-dependent induction of TNFalpha expression by the environmental contaminant benzo(a)pyrene in primary human macrophages. FEBS Lett. 2005, 579:1904-1910.
27. Li Q., Verma I.M. NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2002, 2:725-734.
28. Li W., Matsumura F. Significance of the nongenomic, inflammatory pathway in mediating the toxic action of TCDD to induce rapid and long-term cellular responses in 3T3-L1 adipocytes. Biochemistry 2008, 47:13997-14008.
29. Li W., Vogel C.F., Wu D., Matsumura F. Non-genomic action of TCDD to induce inflammatory responses in HepG2 human hepatoma cells and in liver of C57BL/6J mice. Biol Chem. 2010, 391:1205-1219.
30. Li Z.W., Rickert R.C., Karin M. Genetic dissection of antigen receptor induced-NF-kappaB activation. Mol. Immunol. 2004, 41:701-714.
31. Manikkam M., Tracey R., Guerrero-Bosagna C., Skinner M.K. Dioxin (TCDD) induces epigenetic transgenerational inheritance of adult onset disease and sperm epimutations. PLoS ONE 2012, 7:e46249.
32. Mariussen E., Fonnum F. Neurochemical targets and behavioral effects of organohalogen compounds: an update. Crit. Rev. Toxicol. 2006, 36:253-289.
33. Matsumura F. The significance of the nongenomic pathway in mediating inflammatory signaling of the dioxin-activated Ah receptor to cause toxic effects. Biochem. Pharmacol. 2009, 77:608-626.
34. Memet S. NF-kappaB functions in the nervous system: from development to disease. Biochem. Pharmacol. 2006, 72:1180-1195.
35. Nikodemova M., Duncan I.D., Watters J.J. Minocycline exerts inhibitory effects on multiple mitogen-activated protein kinases and IkappaBalpha degradation in a stimulus-specific manner in microglia. J. Neurochem. 2006, 96:314-323.
36. Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999, 18:6853-6866.
37. Parmentier J.H., Muthalif M.M., Saeed A.E., Malik K.U. Phospholipase D activation by norepinephrine is mediated by 12(s)-, 15(s)-, and 20-hydroxyeicosatetraenoic acids generated by stimulation of cytosolic phospholipase A2. tyrosine phosphorylation of phospholipase D2 in response to norepinephrine. J. Biol. Chem. 2001, 276:15704-15711.
38. Pennica D., Nedwin G.E., Hayflick J.S., Seeburg P.H., Derynck R., Palladino M.A., Kohr W.J., Aggarwal B.B., Goeddel D.V. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 1984, 312:724-729.
39. Puga A., Barnes S.J., Chang C., Zhu H., Nephew K.P., Khan S.A., Shertzer H.G. Activation of transcription factors activator protein-1 and nuclear factor-kappaB by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem. Pharmacol. 2000, 59:997-1005.
40. Puga A., Hoffer A., Zhou S., Bohm J.M., Leikauf G.D., Shertzer H.G. Sustained increase in intracellular free calcium and activation of cyclooxygenase-2 expression in mouse hepatoma cells treated with dioxin. Biochem. Pharmacol. 1997, 54:1287-1296.
41. Ryu J.K., Shin W.H., Kim J., Joe E.H., Lee Y.B., Cho K.G., Oh Y.J., Kim S.U., Jin B.K. Trisialoganglioside GT1b induces in vivo degeneration of nigral dopaminergic neurons: role of microglia. Glia 2002, 38:15-23.
42. Sciullo E.M., Dong B., Vogel C.F., Matsumura F. Characterization of the pattern of the nongenomic signaling pathway through which TCDD-induces early inflammatory responses in U937 human macrophages. Chemosphere 2009, 74:1531-1537.
43. Sciullo E.M., Vogel C.F., Li W., Matsumura F. Initial and extended inflammatory messages of the nongenomic signaling pathway of the TCDD-activated Ah receptor in U937 macrophages. Arch. Biochem. Biophys. 2008, 480:143-155.
44. Sciullo E.M., Vogel C.F., Wu D., Murakami A., Ohigashi H., Matsumura F. Effects of selected food phytochemicals in reducing the toxic actions of TCDD and p,p'-DDT in U937 macrophages. Arch. Toxicol. 2010, 84:957-966.
45. Sul D., Kim H.S., Cho E.K., Lee M., Jung W.W., Hwang K.W., Park S.Y. 2,3,7,8-TCDD neurotoxicity in neuroblastoma cells is caused by increased oxidative stress, intracellular calcium levels, and tau phosphorylation. Toxicology 2009, 255:65-71.
46. Taylor M.J., Lucier G.W., Mahler J.F., Thompson M., Lockhart A.C., Clark G.C. Inhibition of acute TCDD toxicity by treatment with anti-tumor necrosis factor antibody or dexamethasone. Toxicol. Appl. Pharmacol. 1992, 117:126-132.
47. Tsao N., Hsu H.P., Wu C.M., Liu C.C., Lei H.Y. Tumour necrosis factor-alpha causes an increase in blood-brain barrier permeability during sepsis. J. Med. Microbiol. 2001, 50:812-821.
48. Tuttolomondo A., Di Raimondo D., di Sciacca R., Pinto A., Licata G. Inflammatory cytokines in acute ischemic stroke. Curr. Pharm. Des. 2008, 14:3574-3589.
49. Ueno N., Murakami M., Tanioka T., Fujimori K., Tanabe T., Urade Y., Kudo I. Coupling between cyclooxygenase, terminal prostanoid synthase, and phospholipase A2. J. Biol. Chem. 2001, 276:34918-34927.
50. Vogel C.F., Matsumura F. A new cross-talk between the aryl hydrocarbon receptor and RelB, a member of the NF-kappaB family. Biochem. Pharmacol. 2009, 77:734-745.
51. Vogel C.F., Sciullo E., Park S., Liedtke C., Trautwein C., Matsumura F. Dioxin increases C/EBPbeta transcription by activating cAMP/protein kinase A. J. Biol. Chem. 2004, 279:8886-8894.
52. Xue Y., Wu J., Sun J. Four types of inorganic nanoparticles stimulate the inflammatory reaction in brain microglia and damage neurons in vitro. Toxicol. Lett. 2012, 214:91-98.
53. Yang W., Zheng Y., He H., Zhang H., Wan L., Zhang Q., Yu Z. Inhibition of trauma-associated inflammatory liver damage by blocking NF-kappaB activity. Hepatogastroenterology 2012, 59:1174-1178.
54. Zhong H., SuYang H., Erdjument-Bromage H., Tempst P., Ghosh S. The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 1997, 89:413-424.